TMCnet News

Saudi Arabia Healthcare, Regulatory and Reimbursement Landscape Report 2016 - Research and Markets
[July 29, 2016]

Saudi Arabia Healthcare, Regulatory and Reimbursement Landscape Report 2016 - Research and Markets


Research and Markets has announced the addition of the "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Saudi Arabia" report to their offering.

The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Saudi Arabia. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Saudi Arabia.

Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by Our team of industry experts.

In 2015, Saudi Arabia's population was approximately at 31.5 million. The government of Saudi Arabia has been making continuous efforts to strengthen the economy to ensure long-term growth, and the pharmaceutical market is seen as a key industry for the country's future growh. To support this industry, the government has improved regulatory guidelines and initiatives to develop the domestic pharmaceutical market.



The Saudi pharmaceutical market is one of the largest in the Middle East and the largest of the Gulf Co-operation Council (GCC) members, estimated to be worth $4.5 billion in 2015 and expected to reach $6 billion by 2020. The market grew nominally at a Compound Annual Growth Rate (CAGR) of 7.4% over the 2008-2020 period. The medical device market was valued at $1.3 billion in 2008 and is expected to reach approximately $1.8 billion by 2020, at a projected CAGR of 4.6%.

These positive trends can primarily be attributed to


- An increasing elderly population in Saudi Arabia, leading to increases in disease incidence and prevalence as well as higher need for long-term care and medical devices

- Increasing awareness in the medical community and the general population regarding early disease detection and diagnosis, leading to higher rates of adoption of treatments and healthcare

Key Topics Covered:

1 Tables & Figures

2 Introduction

3 Overview of the Pharmaceutical and Medical Device Market

4 Market Access

5 Country Analysis

6 Opportunities and Challenges

7 Appendix

Companies Mentioned

  • GlaxoSmithKline
  • Pfizer
  • Novartis
  • SPIMACO
  • Tabuk Pharmaceuticals
  • Siemens (News - Alert) Healthcare
  • GE Healthcare
  • Roche
  • Philips Healthcare
  • Abbott Laboratories

For more information visit http://www.researchandmarkets.com/research/qgj7sv/countryfocus


[ Back To TMCnet.com's Homepage ]